{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-047122","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.804914+00:00","generated_at":"2026-05-30T02:08:35.220470+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BeautyHealth Q3 net sales $78.8M (-19% YoY); adj. EBITDA $8.1M, revenue guidance cut, EBITDA raised","bullets":["Q3 net sales $78.8M, down 19.1% YoY; delivery systems sales fell 46% to $27.6M, consumables up 10% to $51.2M.","Net loss narrowed to $18.3M from $73.8M; GAAP gross margin improved to 51.6% from -12.9% YoY.","Adjusted EBITDA $8.1M vs $9.1M; adjusted EBITDA margin 10.2% vs 9.3%.","Full-year net sales guidance lowered; adjusted EBITDA guidance improved citing Q3 profitability.","Centralized manufacturing in Long Beach by year-end, ending China partner relationship; new CRO and CMO hired."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-047122","json":"https://secwatch.observer/filing/0001628280-24-047122.json","markdown":"https://secwatch.observer/filing/0001628280-24-047122.md","text":"https://secwatch.observer/filing/0001628280-24-047122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024047122/0001628280-24-047122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024047122/skin-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:08:35.220470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}